Toward precision in psoriatic arthritis: addressing the challenge of difficult-to-treat disease.

INTRODUCTION: Difficult-to-treat psoriatic arthritis (D2T-PsA) is increasingly recognized as a complex clinical entity characterized by persistent disease burden despite multiple targeted therapies. Its identification is essential to improve patient…

Preview only. Read the full abstract at the source